Fassio, Angelo
 Distribuzione geografica
Continente #
EU - Europa 2.418
NA - Nord America 2.363
AS - Asia 1.410
AF - Africa 40
SA - Sud America 24
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.267
Nazione #
US - Stati Uniti d'America 2.349
CN - Cina 832
GB - Regno Unito 509
SG - Singapore 388
IT - Italia 352
DE - Germania 342
RU - Federazione Russa 313
IE - Irlanda 250
SE - Svezia 249
FR - Francia 212
FI - Finlandia 77
JP - Giappone 48
UA - Ucraina 35
VN - Vietnam 30
TG - Togo 27
HK - Hong Kong 22
KR - Corea 20
NL - Olanda 19
ID - Indonesia 18
BR - Brasile 15
CA - Canada 14
TR - Turchia 11
AT - Austria 9
BE - Belgio 9
IR - Iran 9
RO - Romania 9
AU - Australia 8
CH - Svizzera 6
IN - India 6
PT - Portogallo 6
EG - Egitto 5
QA - Qatar 5
ZA - Sudafrica 5
CZ - Repubblica Ceca 4
ES - Italia 4
IQ - Iraq 4
PK - Pakistan 4
AR - Argentina 3
HR - Croazia 3
PH - Filippine 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DK - Danimarca 2
EC - Ecuador 2
SI - Slovenia 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
KE - Kenya 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 6.267
Città #
Chandler 609
Southend 484
Singapore 326
Dublin 245
Ashburn 193
Beijing 149
Jacksonville 130
Redmond 97
Princeton 84
Lawrence 83
Wilmington 78
New York 76
Verona 66
Ann Arbor 62
Jinan 59
Helsinki 57
Shenyang 56
Woodbridge 52
Houston 50
Nanjing 46
Tokyo 46
Bologna 45
Sindelfingen 39
Hebei 34
Tianjin 32
Zhengzhou 29
Haikou 27
Lomé 27
Washington 26
San Francisco 25
Changsha 24
Hangzhou 24
Ningbo 20
Seattle 20
Rome 18
Jakarta 16
Milan 16
Moscow 16
Fairfield 15
Jiaxing 15
Redwood City 15
Taiyuan 15
Dallas 14
Guangzhou 14
Los Angeles 14
Dong Ket 13
Nanchang 13
Santa Clara 13
Seoul 13
Taizhou 13
Chicago 12
Norwalk 11
Nürnberg 10
Brussels 9
Hong Kong 9
Munich 9
Vienna 9
Amsterdam 8
Dongguan 8
Falls Church 8
Florianópolis 8
Bârlad 7
Dearborn 7
Düsseldorf 7
Fuzhou 7
Lanzhou 7
Boydton 6
Detroit 6
Kent 6
London 6
Seo-gu 6
Shanghai 6
Toronto 6
Des Moines 5
Esslingen am Neckar 5
Falkenstein 5
Romola 5
Bari 4
Cagliari 4
Easton 4
Miami 4
Trieste 4
Zurich 4
Biandronno 3
Canberra 3
Central 3
Faenza 3
Frankfurt am Main 3
Genova 3
Kemerovo 3
Lancaster 3
Lappeenranta 3
Las Vegas 3
Madrid 3
Mansehra 3
Mehlingen 3
Ottawa 3
Padova 3
Riva 3
Saint-Etienne 3
Totale 3.926
Nome #
Teriparatide and denosumab combination therapy and skeletal metabolism 248
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 121
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 119
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 113
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 111
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 108
Anti-CCP antibodies and bone 104
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 101
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 101
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 100
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 97
Periostin: The bone and beyond 95
Duration of treatment for osteoporosis 92
Drug-induced osteonecrosis of the jaw: the state of the art 91
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 91
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 90
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 90
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 88
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 86
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 86
The obesity paradox and osteoporosis 84
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 84
Rheumatoid arthritis, γδ T cells and bisphosphonates 83
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 82
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 77
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 75
Effects of secukinumab on serum adipocytokines: preliminary data 74
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 74
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 73
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 73
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 73
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 72
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 71
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 71
Vitamin D: not just bone, but also immunity 70
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 70
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 70
Association between environmental air pollution and rheumatoid arthritis flares 70
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 66
Correction to: The obesity paradox and osteoporosis 65
Insight into the WNT system and its drug related response. 64
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 64
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 62
Wnt pathway involvement and its response to treatment in the development of bone damage in different inflammatory and non-inflammatory rheumatic contidions 62
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis 61
Association between increased carotid intima-media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes 61
Osteoporosis in Rheumatic Diseases 61
Calcium and vitamin D supplementation: when and why 61
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 60
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 58
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 58
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 58
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 56
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 55
Radiological features of knee joint synovial chondromatosis 54
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 54
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 54
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 52
Bone Geometry, Quality, and Bone Markers in Children with Type 1 Diabetes Mellitus 52
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 52
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 51
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 51
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 51
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 51
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 50
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 50
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 50
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 49
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 48
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 48
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 47
Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures 45
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis 44
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 43
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 43
Nail ultrasonography for psoriatic arthritis and psoriasis patients: a systematic literature review 42
Pharmacological management of osteoporosis in postmenopausal women: The current state of the art 42
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 42
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 41
Ultrasonographic detection, definition and quantification of soft tissue oedema in psoriatic dactylitis 39
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 38
Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) 37
Vitamin D and Osteogenesis Imperfecta in Pediatrics 35
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 34
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 33
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 33
Association between acute exposure to environmental air pollution and fragility hip fractures 30
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes 30
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 29
Cardiovascular Safety of Romosozumab: New Insights from Postmenopausal Women with Chronic Kidney Disease 28
Clinical image: ultrasound findings and magnetic resonance imaging comparison in the muscular involvement in polyarteritis nodosa 27
Bone loss occurs in Inflammatory Rheumatic Musculoskeletal Diseases (iRMD) patients treated with low dose glucocorticoids, but is prevented by anti-osteoporosis medications 26
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 26
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 25
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 25
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 23
Bone health status evaluation in men by means of REMS technology 23
Osteoimmunology of Spondyloarthritis 23
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 22
Discontinuation of infliximab leading to auditory loss in a patient with Cogan syndrome: A case report 21
Totale 6.263
Categoria #
all - tutte 28.719
article - articoli 28.060
book - libri 0
conference - conferenze 386
curatela - curatele 0
other - altro 273
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.438


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020349 0 0 0 0 54 66 53 8 42 34 30 62
2020/2021717 105 120 26 118 76 50 42 5 52 8 64 51
2021/2022692 62 164 12 43 23 23 19 31 54 24 36 201
2022/20231.724 98 175 142 329 157 400 17 87 206 28 66 19
2023/20241.120 37 89 101 124 110 220 60 59 30 63 171 56
2024/2025965 114 127 126 450 148 0 0 0 0 0 0 0
Totale 6.485